| Neurologic alterations due to respiratory virus infections K Bohmwald, NMS Gálvez, M Ríos, AM Kalergis Frontiers in cellular neuroscience 12, 386, 2018 | 779 | 2018 |
| Safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a subgroup of healthy adults in Chile SM Bueno, K Abarca, PA González, NMS Gálvez, JA Soto, LF Duarte, ... Clinical Infectious Diseases 75 (1), e792-e804, 2022 | 186* | 2022 |
| Contribution of cytokines to tissue damage during human respiratory syncytial virus infection K Bohmwald, NMS Gálvez, G Canedo-Marroquín, MS Pizarro-Ortega, ... Frontiers in immunology 10, 452, 2019 | 86 | 2019 |
| Recognition of variants of concern by antibodies and T cells induced by a SARS-CoV-2 inactivated vaccine F Melo-González, JA Soto, LA González, J Fernández, LF Duarte, ... Frontiers in immunology 12, 747830, 2021 | 77 | 2021 |
| Immune profile and clinical outcome of breakthrough cases after vaccination with an inactivated SARS-CoV-2 vaccine LF Duarte, NMS Gálvez, C Iturriaga, F Melo-González, JA Soto, ... Frontiers in immunology 12, 742914, 2021 | 74 | 2021 |
| The role of dendritic cells during infections caused by highly prevalent viruses JA Soto, NMS Gálvez, CA Andrade, GA Pacheco, K Bohmwald, ... Frontiers in immunology 11, 1513, 2020 | 70 | 2020 |
| Human metapneumovirus: mechanisms and molecular targets used by the virus to avoid the immune system JA Soto, NMS Gálvez, FM Benavente, MS Pizarro-Ortega, MK Lay, ... Frontiers in immunology 9, 2466, 2018 | 52 | 2018 |
| Recombinant BCG vaccines reduce pneumovirus-caused airway pathology by inducing protective humoral immunity JA Soto, NMS Gálvez, CA Rivera, CE Palavecino, PF Céspedes, ... Frontiers in immunology 9, 2875, 2018 | 49 | 2018 |
| A booster dose of CoronaVac increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern BM Schultz, F Melo-González, LF Duarte, NMS Gálvez, GA Pacheco, ... MBio 13 (4), e01423-22, 2022 | 44* | 2022 |
| Antibody development for preventing the human respiratory syncytial virus pathology JA Soto, NMS Gálvez, GA Pacheco, SM Bueno, AM Kalergis Molecular Medicine 26, 1-10, 2020 | 40 | 2020 |
| The causes and long-term consequences of viral encephalitis K Bohmwald, CA Andrade, NMS Gálvez, VP Mora, JT Muñoz, AM Kalergis Frontiers in Cellular Neuroscience 15, 755875, 2021 | 39 | 2021 |
| Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial K Abarca, E Rey-Jurado, N Munoz-Durango, Y Vázquez, JA Soto, ... EClinicalMedicine 27, 2020 | 38 | 2020 |
| Contribution of hypoxia inducible factor-1 during viral infections A Reyes, N Corrales, NMS Gálvez, SM Bueno, AM Kalergis, PA González Virulence 11 (1), 1482-1500, 2020 | 36 | 2020 |
| A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus E Rey-Jurado, J Soto, N Gálvez, AM Kalergis Human vaccines & immunotherapeutics 13 (9), 2092-2097, 2017 | 33 | 2017 |
| BCG vaccination induces cross-protective immunity against pathogenic microorganisms JA Soto, NMS Gálvez, CA Andrade, MA Ramírez, CA Riedel, AM Kalergis, ... Trends in Immunology 43 (4), 322-335, 2022 | 31 | 2022 |
| Bacterial and viral coinfections with the human respiratory syncytial virus GA Pacheco, NMS Gálvez, JA Soto, CA Andrade, AM Kalergis Microorganisms 9 (6), 1293, 2021 | 30 | 2021 |
| Type I natural killer T cells as key regulators of the immune response to infectious diseases NMS Gálvez, K Bohmwald, GA Pacheco, CA Andrade, LJ Carreño, ... Clinical Microbiology Reviews 34 (2), 10.1128/cmr. 00232-20, 2021 | 29 | 2021 |
| New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus MK Lay, SM Bueno, N Gálvez, CA Riedel, AM Kalergis Critical reviews in microbiology 42 (5), 800-812, 2016 | 27 | 2016 |
| SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study M Dib, N Le Corre, C Ortiz, D García, M Ferrés, C Martinez-Valdebenito, ... The Lancet Regional Health–Americas 16, 2022 | 24 | 2022 |
| Innate immune components that regulate the pathogenesis and resolution of hRSV and hMPV infections CA Andrade, GA Pacheco, NMS Gálvez, JA Soto, SM Bueno, AM Kalergis Viruses 12 (6), 637, 2020 | 21 | 2020 |
Karen BohmwaldInstituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile,在 uautonoma.cl 的电子邮件经过验证
